Gigagen, Inc.

Gigagen, Inc. is a biotech company in South San Francisco, United States, founded in 2015. It has raised $90.0M across 7 rounds, most recently a $50.0M Corporate Round in March 2021.

GigaGen - Antibody Drug Discovery With Single Cell Technology

Employees
1–10
Founded
2015
Total Funding
$90.0M
Last Round
$50.0M Corporate RoundMar 2021
Rounds
7

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 7 funding rounds and 3 investors for this company. The full record is or through the API.

About

GigaGen develops recombinant monoclonal and polyclonal antibody therapeutics using its drug discovery platform. The platform provides the basis for developing antibody therapies with distinctive mechanisms of action, bringing monoclonal and polyclonal approaches into its therapeutic discovery and development work.

Summary

It lists 1–10 employees. It has raised $90.0M in total across 7 rounds, most recently a $50.0M Corporate Round in Mar 2021. Investors include Grifols, National Science Foundation and National Cancer Institute.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Data from Indexed.vcUpdated
Corporate RoundCorporate RoundMar 2021
$50.0M

Sign up to see all 7 events

Funding: Grant through Corporate Round. Amounts, valuations, and investors where available.

Investors

Similar Companies

Alnylam PharmaceuticalsIPO

Biopharmaceutical company developing and commercializing RNAi therapeutics to treat genetically d...

Cambridge, United States1001–5000Biotech, Genomics
Corporate RoundTotal funding$1.0BApr 2020
GRAILIPO

Biotechnology company developing multi-cancer early detection blood tests using high-intensity ge...

Menlo Park, United States1001–5000Biotech, Genomics
Corporate RoundTotal funding$2.1BJun 2026
Paratek PharmaceuticalsAcquired

Paratek Pharmaceuticals develops and delivers innovative treatments for serious infectious diseas...

Boston, United States201–500Biotech, Healthcare
ConvertibleTotal funding$1.8BApr 2018
Sana BiotechnologyIPO

Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...

Seattle, United States201–500Biotech, Healthcare
Series DTotal funding$1.4BJun 2020
Abogen Biosciences

Abogen Biosciences develops RNA therapeutics using integrated mRNA design, lipid nanoparticle del...

Suzhou, China201–500Biotech, Drug Discovery
Extension RoundTotal funding$1.2BNov 2021
Ultima Genomics

Ultima Genomics develops high-throughput DNA sequencing platforms that use open-wafer technology ...

Fremont, United States201–500Artificial Intelligence, Healthcare
Series ETotal funding$1.1BJun 2022

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Gigagen, Inc. on Indexed.vc
<a href="https://indexed.vc/companies/gigagen-inc"><img src="https://indexed.vc/api/badge/company/gigagen-inc" alt="Gigagen, Inc. on Indexed.vc" width="260" height="76" /></a>